Related Experiment Video
Updated: Jul 4, 2026

Measuring Delay Discounting in Humans Using an Adjusting Amount Task
Published on: January 9, 2016
Comparison of two methods of eliciting time preference for future health states
Marjon van der Pol1, John Cairns
1Health Economics Research Unit, University Medical Buildings, University of Aberdeen, Foresterhill, Aberdeen, Scotland AB25 2ZD, UK. m.vanderpol@abdn.ac.uk
Abstract:
Mean estimates of time preference rates for health vary widely in the literature. If these studies are to inform discounting practice and analyses of health-affecting behaviour, it is crucial to understand why this is the case. One reason for the variation in time preference rates is the use of different elicitation methods. The influence of elicitation method has received little attention in the time preference literature. This study compares directly an open-ended and a closed-ended method. Both private and social time preferences for health are elicited. The closed-ended method produced much lower mean rates than the open-ended method. This is in contrast to the contingent valuation literature which shows that closed-ended methods produce higher estimates of willingness to pay than open-ended methods. That the elicitation methods produce different mean estimates is clearly worrying if the interest is in estimating the true time preference rate. However, the results of this study suggest that if the interest is in testing different types of time preferences or investigating the relationship between time preference and individual characteristics then the choice of elicitation method is less important.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
The Availability Heuristic
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time until a...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Kaplan-Meier Approach
Measurement of Bioavailability: Pharmacodynamic Methods

